EP Patent

EP1318978B1 — N-acylsulfonamide apoptosis promoters

Assigned to Abbott Laboratories · Expires 2006-02-08 · 20y expired

What this patent protects

N-Benzoyl arylsulfonamides having the formula (I) are BCL-Xl inhibitors and are useful for promoting apoptosis. Also disclosed are BCL-Xl inhibiting compositions and methods of promoting apoptosis in a mammal.

USPTO Abstract

N-Benzoyl arylsulfonamides having the formula (I) are BCL-Xl inhibitors and are useful for promoting apoptosis. Also disclosed are BCL-Xl inhibiting compositions and methods of promoting apoptosis in a mammal.

Drugs covered by this patent

Patent Metadata

Patent number: EP1318978B1
Jurisdiction: EP
Classification: —
Expires: 2006-02-08
Drug substance claim: No
Drug product claim: No
Assignee: Abbott Laboratories
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.